With multiple novel therapies expected and the treatment paradigm shifting toward earlier intervention, the market will grow ...

Dupilumab may provide a nonsteroidal option for managing cancer therapy-related skin toxicities, according to a study.

Regeneron Pharmaceuticals (($REGN)) announced an update on their ongoing clinical study. Regeneron Pharmaceuticals is conducting a clinical study ...

Moving on, Regeneron’s second-quarter report was largely positive. Total revenues of $3.68 billion (up 4% YoY) beat analyst ...

Rothschild & Co Redburn initiated coverage of Regeneron (REGN) with a Buy rating and $890 price target Published first on TheFly – the ultimate ...

Among adults with severe asthma, those with healthy weight, overweight, obesity and severe obesity each had improvements in ...

The jury in Sean “Diddy” Combs’ sex trafficking trial said Tuesday that it has reached a verdict on four of five counts against the hip-hop mogul.